SHOX2 and lung carcinoma: Methylation of the SHOX2 gene locus in bronchial fluid aspirated during bronchoscopy is a validated biomarker in patients with suspected lung cancer and allowed for accurate detection of malignant lung disease even in patients with a negative cytopathological result and no visible tumor in bronchoscopy [26], [27].